During the past decade, University of Alabama at Birmingham/Center for Women's Reproductive Health conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Alabama at Birmingham/Center for Women's Reproductive Health" #1 collaborator was "Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "University of Alabama at Birmingham/Center for Women's Reproductive Health" are "COVID-19" (2 trials), "Gingivitis" (2 trials), "Maternal Immunization" (1 trials), "Pregnancy" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "University of Alabama at Birmingham/Center for Women's Reproductive Health" in a lesser frequency.

Most popular intervention types in "University of Alabama at Birmingham/Center for Women's Reproductive Health" are "Biological" (2 trials), "Drug" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "0.07% Cetylpyridinium chloride" (1 trials), "0.243% sodium fluoride" (1 trials), "0.454% stannous fluoride" (1 trials) and "BNT162b2" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Alabama at Birmingham/Center for Women's Reproductive Health" are 4 trials for "Female" genders and 1 trials for "All" genders.

Currently, there are NaN active trials in "University of Alabama at Birmingham/Center for Women's Reproductive Health". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in University of Alabama at Birmingham/Center for Women's Reproductive Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in University of Alabama at Birmingham/Center for Women's Reproductive Health, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".